Literature DB >> 33255431

Polarized Cytokine Release Triggered by P2X7 Receptor from Retinal Pigmented Epithelial Cells Dependent on Calcium Influx.

Xiaolei Shao1,2, Sonia Guha2,3, Wennan Lu4, Keith E Campagno4, Jonathan M Beckel2,5, Jason A Mills6,7, Wenli Yang8, Claire H Mitchell2,4,6,9.   

Abstract

Cytokine release from non-inflammatory cells is a key step in innate immunity, and agonists triggering cytokine release are central in coordinating responses. P2X7 receptor (P2X7R) stimulation by extracellular ATP is best known to active the NLRP3 inflammasome and release IL-1β, but stimulation also leads to release of other cytokines. As cytokine signaling by retinal pigmented epithelial (RPE) cells is implicated in retinal neurodegeneration, the role of P2X7R in release of cytokine IL-6 from RPE cells was investigated. P2X7R stimulation triggered IL-6 release from primary mouse RPE, human iPS-RPE and human ARPE-19 cells. IL-6 release was polarized, with predominant rise across apical membranes. IL-6 release was inhibited by P2X7R antagonists A438079, A839977, and AZ10606120, but not the NRTI lamivudine (3TC), P2X1R antagonist NF279, or P2Y1R antagonist MRS2179. P2X7R-mediated IL-6 release required extracellular Ca2+ and was blocked by Ca2+ chelator BAPTA. IL-6 release and Ca2+ elevation occurred rapidly, consistent with vesicular IL-6 staining in unstimulated cells. P2X7R stimulation did not trigger IL-1β release in these unprimed cells. P2X7R-mediated IL-6 release was enhanced in RPE cells from the ABCA4-/- mouse model of retinal degeneration. In summary, P2X7R stimulation triggers rapid Ca2+-dependent IL-6 release across the apical membrane of RPE cells.

Entities:  

Keywords:  IL-1β; IL-6; P2X7; calcium-dependent vesicular release; cytokine release; inflammation; innate immunity; retina

Mesh:

Substances:

Year:  2020        PMID: 33255431      PMCID: PMC7760537          DOI: 10.3390/cells9122537

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   7.666


  73 in total

Review 1.  International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.

Authors:  B S Khakh; G Burnstock; C Kennedy; B F King; R A North; P Séguéla; M Voigt; P P Humphrey
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

Review 2.  Plasma membrane protein polarity and trafficking in RPE cells: past, present and future.

Authors:  Guillermo L Lehmann; Ignacio Benedicto; Nancy J Philp; Enrique Rodriguez-Boulan
Journal:  Exp Eye Res       Date:  2014-09       Impact factor: 3.467

3.  Interleukin-6 plays a crucial role in the development of subretinal fibrosis in a mouse model.

Authors:  Kota Sato; Atsunobu Takeda; Eiichi Hasegawa; Young-Joon Jo; Mitsuru Arima; Yuji Oshima; Yanai Ryoji; Toru Nakazawa; Mitsuko Yuzawa; Hiroyuki Nakashizuka; Hiroyuki Shimada; Kazuhiro Kimura; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  Immunol Med       Date:  2018-04-05

4.  Pigment epithelial cell ensheathment of cone outer segments in the retina of the domestic cat.

Authors:  R H Steinberg; I Wood
Journal:  Proc R Soc Lond B Biol Sci       Date:  1974-11-19

5.  Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.

Authors:  P Vigne; B Hechler; C Gachet; J P Breittmayer; C Frelin
Journal:  Biochem Biophys Res Commun       Date:  1999-03-05       Impact factor: 3.575

6.  NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration.

Authors:  Wen Allen Tseng; Thuzar Thein; Kati Kinnunen; Kameran Lashkari; Meredith S Gregory; Patricia A D'Amore; Bruce R Ksander
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-07       Impact factor: 4.799

Review 7.  IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.

Authors:  Stefan Rose-John
Journal:  Int J Biol Sci       Date:  2012-10-24       Impact factor: 6.580

Review 8.  Immune Homeostasis in Epithelial Cells: Evidence and Role of Inflammasome Signaling Reviewed.

Authors:  Paul M Peeters; Emiel F Wouters; Niki L Reynaert
Journal:  J Immunol Res       Date:  2015-08-19       Impact factor: 4.818

Review 9.  Non-nucleotide Agonists Triggering P2X7 Receptor Activation and Pore Formation.

Authors:  Francesco Di Virgilio; Anna L Giuliani; Valentina Vultaggio-Poma; Simonetta Falzoni; Alba C Sarti
Journal:  Front Pharmacol       Date:  2018-02-01       Impact factor: 5.810

10.  Stimulation of TLR3 triggers release of lysosomal ATP in astrocytes and epithelial cells that requires TRPML1 channels.

Authors:  Jonathan M Beckel; Néstor Más Gómez; Wennan Lu; Keith E Campagno; Bardia Nabet; Farraj Albalawi; Jason C Lim; Kathleen Boesze-Battaglia; Claire H Mitchell
Journal:  Sci Rep       Date:  2018-04-10       Impact factor: 4.379

View more
  4 in total

Review 1.  Lipid metabolism and ageing in Caenorhabditis elegans: a complex interplay.

Authors:  Teresa Rubio-Tomás; Nektarios Tavernarakis
Journal:  Biogerontology       Date:  2022-09-01       Impact factor: 4.284

2.  The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells.

Authors:  Lara Magni; Rayhana Bouazzi; Hugo Heredero Olmedilla; Patricia S S Petersen; Marco Tozzi; Ivana Novak
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

3.  Rapid morphologic changes to microglial cells and upregulation of mixed microglial activation state markers induced by P2X7 receptor stimulation and increased intraocular pressure.

Authors:  Keith E Campagno; Wennan Lu; Assraa Hassan Jassim; Farraj Albalawi; Aurora Cenaj; Huen-Yee Tso; Sophia P Clark; Puttipong Sripinun; Néstor Más Gómez; Claire H Mitchell
Journal:  J Neuroinflammation       Date:  2021-09-20       Impact factor: 8.322

4.  The P2X7 Receptor in Microglial Cells Modulates the Endolysosomal Axis, Autophagy, and Phagocytosis.

Authors:  Keith E Campagno; Claire H Mitchell
Journal:  Front Cell Neurosci       Date:  2021-03-15       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.